CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
137 hedge funds and large institutions have $328M invested in Cymabay Therapeutics in 2019 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 43 increasing their positions, 38 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
32% less capital invested
Capital invested by funds: $485M → $328M (-$157M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
137
Holding in Top 10
1
Calls
$5.58M
Puts
$44K
Top Buyers
| 1 | +$3.79M | |
| 2 | +$2.38M | |
| 3 | +$2.34M | |
| 4 |
Morgan Stanley
New York
|
+$2.14M |
| 5 |
Citigroup
New York
|
+$2.1M |
Top Sellers
| 1 | -$15.4M | |
| 2 | -$12M | |
| 3 | -$3.78M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$2.87M |
| 5 |
FCMI
Foresite Capital Management IV
Larkspur,
California
|
-$2.62M |